Peter Spégel
Corporate Officer/Principal presso University of Lund
Profilo
Peter Spégel is the founder of Nanosep AB, which was founded in 2003.
He held the title of Director from 2010 to 2011.
Currently, he is a Principal at the University of Lund.
Dr. Spégel's education includes a graduate and doctorate degree from the University of Lund.
Posizioni attive di Peter Spégel
Società | Posizione | Inizio |
---|---|---|
University of Lund | Corporate Officer/Principal | 01/12/2009 |
Precedenti posizioni note di Peter Spégel
Società | Posizione | Fine |
---|---|---|
Nanosep AB
Nanosep AB Miscellaneous Commercial ServicesCommercial Services Nanosep is a company with a new high performing environmentally friendly analytical technology to be used in the pharmaceutical and biotech industry. With the Nanosep technology, a customer can easily get results from complicated samples such as blood plasma and pharmaceutical products. Both faster, with less effort and with higher precision compared to technologies available on the market. Transmission electron microscopy image of a prototype to Nanosep RP. One unique feature in the separation process is that the equipment is self regenerated continuously, which enables a user to perform all separations on a new fresh column. The technology is consequently designed to be able to handle complicated and contaminating samples, such as blood plasma and advanced drug formulations. The unique technology is based on Nanoseps patented polymer nanoparticles, the Nanosep RP. The business concept of Nanosep AB is to commercialize Nanosep RP and to develop a family of products. Nanosep RP will be sold in small vials that the user directly can use with his existing equipment. With Nanosep RP, the performance and stability of the system will be greatly improved, which will give user satisfaction through reliable information and rich data on projects. | Fondatore | 21/12/2011 |
Formazione di Peter Spégel
University of Lund | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Nanosep AB
Nanosep AB Miscellaneous Commercial ServicesCommercial Services Nanosep is a company with a new high performing environmentally friendly analytical technology to be used in the pharmaceutical and biotech industry. With the Nanosep technology, a customer can easily get results from complicated samples such as blood plasma and pharmaceutical products. Both faster, with less effort and with higher precision compared to technologies available on the market. Transmission electron microscopy image of a prototype to Nanosep RP. One unique feature in the separation process is that the equipment is self regenerated continuously, which enables a user to perform all separations on a new fresh column. The technology is consequently designed to be able to handle complicated and contaminating samples, such as blood plasma and advanced drug formulations. The unique technology is based on Nanoseps patented polymer nanoparticles, the Nanosep RP. The business concept of Nanosep AB is to commercialize Nanosep RP and to develop a family of products. Nanosep RP will be sold in small vials that the user directly can use with his existing equipment. With Nanosep RP, the performance and stability of the system will be greatly improved, which will give user satisfaction through reliable information and rich data on projects. | Commercial Services |
- Borsa valori
- Insiders
- Peter Spégel